
The Hidden Metric Behind Shareholder Value
New approaches offer an evolution in economic profit measurement worth considering. Here’s wh…

New approaches offer an evolution in economic profit measurement worth considering. Here’s wh…

Introduction In an era of market volatility, technological disruption, and evolving customer ex…

The calm before the looming annual planning storm offers an opportunity to frame out high-impac…

Build an effective sales force by redirecting its energy toward value maximization.

Here are the key challenges that companies face in optimally allocating resources and a framewo…

For the past 70 years, Varian Medical Systems has helped lead the fight against cancer by devel…

How finance and investor relations can lead a cultural transformation that drives long-term sha…

ISS is adopting a metric that may impact how investors evaluate pay practices. Companies that d…

Strong opportunity and accountability exist in an ownership culture and both public and private…

Should publicly held, early stage biotechs issue more shares or partner with Big Pharma?

According to “Health, United States, 2015,” a report published by the U.S. Department of He…

They're great for investment bankers and sellers, but lower valuation multiples are associated …

ABOUT FORTUNA ADVISORS
Our team has advised hundreds of clients on developing a new approach to creating exceptional value for stakeholders and shareholders. Our differentiated cash-based earnings approach to strategic management and capital allocation draws on years of experience as advisors and investors at Credit Suisse, Morgan Stanley, Lehman Brothers, DLJ, Stern Stewart, Marakon, Ernst & Young, and ISS.
© 2026 FORTUNA ADVISORS – ALL RIGHTS RESERVED